An Overview of Nanostructured Lipid Carriers and its Application in Drug Delivery through Different Routes
- PMID: 37646052
- PMCID: PMC10460807
- DOI: 10.34172/apb.2023.056
An Overview of Nanostructured Lipid Carriers and its Application in Drug Delivery through Different Routes
Abstract
Nanostructured Lipid Carriers (NLC) are nano-sized colloidal drug delivery system that contains a lipid mixture consisting of both solid and liquid lipids in their core. This Lipid-Based Nanosystem is introduced as a biocompatible, non-toxic, and safe nano-drug delivery system as compared to polymeric or metallic nanoparticles. Due to its safety, stability, and high drug loading capacity compared to other lipid-based nanocarriers, NLC gained the attention of researchers to formulate safe and effective drug carriers. The ability to increase drug solubility and permeability while encapsulating the drug in a lipidic shell makes them an ideal carrier for drug delivery through difficult-to-achieve routes. Surface modification of NLC and the use of various additives result in drug targeting and increased residence time. With such qualities, NLCs can be used to treat a variety of diseases such as cancer, infections, neurodegenerative diseases, hypertension, diabetes, and pain management. This review focuses on the recent developments being made to deliver the drugs and genes through different routes via these nanocarriers. Here, we also discuss about historical background, structure, types of NLC and commonly employed techniques for manufacturing lipid-based nanocarriers.
Keywords: Drug carriers; Drug delivery systems; Intransal; Lipids; Ophthalmic; Oral; Permeability; nanoparticles.
©2023 The Authors.
Conflict of interest statement
None.
Figures
Similar articles
-
Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration.Curr Med Chem. 2020;27(22):3623-3656. doi: 10.2174/0929867326666190624155938. Curr Med Chem. 2020. PMID: 31232233 Review.
-
Nanostructured Lipid Carrier-based Topical Gels as Novel Drug Delivery System: A Comprehensive Overview.Curr Drug Deliv. 2024 Oct 18. doi: 10.2174/0115672018335655241015062436. Online ahead of print. Curr Drug Deliv. 2024. PMID: 39428928
-
Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.J Control Release. 2020 May 10;321:372-415. doi: 10.1016/j.jconrel.2020.02.020. Epub 2020 Feb 12. J Control Release. 2020. PMID: 32061621 Review.
-
Nanostructured lipid carriers system: recent advances in drug delivery.J Drug Target. 2012 Dec;20(10):813-30. doi: 10.3109/1061186X.2012.716845. Epub 2012 Aug 29. J Drug Target. 2012. PMID: 22931500 Review.
-
Nano Lipid Carriers as a Promising Drug Delivery Carrier for Neurodegenerative Disorders - An Overview of Recent Advances.Recent Pat Biotechnol. 2024;18(1):2-21. doi: 10.2174/1872208317666230320164219. Recent Pat Biotechnol. 2024. PMID: 38205772 Review.
Cited by
-
Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy.Int J Mol Sci. 2024 Jul 11;25(14):7612. doi: 10.3390/ijms25147612. Int J Mol Sci. 2024. PMID: 39062852 Free PMC article. Review.
-
Bioactive Compounds Formulated in Phytosomes Administered as Complementary Therapy for Metabolic Disorders.Int J Mol Sci. 2024 Apr 9;25(8):4162. doi: 10.3390/ijms25084162. Int J Mol Sci. 2024. PMID: 38673748 Free PMC article. Review.
-
Characterization Methods for Nanoparticle-Skin Interactions: An Overview.Life (Basel). 2024 May 8;14(5):599. doi: 10.3390/life14050599. Life (Basel). 2024. PMID: 38792620 Free PMC article. Review.
-
Liposomal and Nanostructured Lipid Nanoformulations of a Pentacyclic Triterpenoid Birch Bark Extract: Structural Characterization and In Vitro Effects on Melanoma B16-F10 and Walker 256 Tumor Cells Apoptosis.Pharmaceuticals (Basel). 2024 Dec 4;17(12):1630. doi: 10.3390/ph17121630. Pharmaceuticals (Basel). 2024. PMID: 39770472 Free PMC article.
-
Emerging nano-derived therapy for the treatment of dementia: a comprehensive review.Drug Deliv Transl Res. 2025 Apr 23. doi: 10.1007/s13346-025-01863-3. Online ahead of print. Drug Deliv Transl Res. 2025. PMID: 40268841
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources